Navigation Links
Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
Date:2/25/2011

Company believes that no patients have been denied reimbursement for KRYSTEXXA.  
  • Staged Roll-out – During the first phase of the launch program, Savient sales teams will target  Rheumatologists and Nephrologists.  Savient anticipates the ramp-up to be slow in this initial phase as the Company conducts infusion center in-service education and works to speed the private and public payer reimbursement processes.  
  • Expanding market opportunities – Savient is on track to complete the EU submission for KRYSTEXXA in the first quarter of 2011 or shortly thereafter.  The Company then expects to execute plans to file in other markets around the world, including Asia where the prevalence of gout is among the highest in the world.

  • Fourth Quarter and Year-End 2010 Financial ResultsSavient also today reported financial results for the three months and year ended December 31, 2010.  Savient ended the quarter with $64.9 million in cash and short-term investments, a decrease of $13.2 million for the quarter and $43.3 million since December 31, 2009.

    For the fourth quarter 2010, the Company had a net loss of $0.5 million, or $0.01 per share, inclusive of a gain from a non-cash valuation adjustment of $18.1 million, relating to a previous warrant liability, on total revenues of $1.0 million.  This compares with a net loss of $0.2 million, or $0.00 per share, on total revenues of $0.9 million for the same period in 2009.

    The net loss for the year ended December 31, 2010 was $73.1 million, or $1.08 per share, on total revenues of $4.0 million, compared with a net loss of $90.9 million, or $1.51 per share, on total revenues of $3.0 million in 2009.  Savient ended 2010 with 70.3 million shares outstanding.

    Operational Highlights:

  • Closed the sale, on February 4, 2011, of $230 million in aggregate principal amount of 4.75% Convertible Senior Notes due 2018
    '/>"/>

  • SOURCE Savient Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011
    2. Savient Closes Sale of $230 Million in Convertible Senior Notes
    3. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
    4. Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
    5. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
    6. Savient Pharmaceuticals Announces Search for CEO
    7. Savient Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
    8. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
    9. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
    10. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
    11. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... Hovione today announced that its API ... passed a pre-approval inspection by the US Food and Drug ... FDA Consumer Safety Officer, Ms. Britanny Terhar , lasted ... July and concluded on the 25 th . The inspection ... guidelines of Good Manufacturing Practices (GMP) and no Form 483 ...
    (Date:7/31/2014)... the list of stocks featured in the Analyst Blog. Every ... and events impacting stocks and the financial markets. Stocks recently ... Free Report ), Gilead (Nasdaq: GILD - Free Report ... AbbVie (NYSE: ABBV - Free Report ) and Celgene ... Zacks is promoting its ,Buy, stock recommendations. Get #1Stock ...
    (Date:7/31/2014)... , July 31, 2014 TB Alliance, a ... and affordable treatments for tuberculosis (TB), announced the appointment ... Market Access. Ms. Robertson joins the organization from Novartis ... in Sub-Saharan Africa and Eastern Europe ... TB Alliance,s efforts to ensure beneficial new TB treatments ...
    Breaking Medicine Technology:Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3
    (Date:7/31/2014)... 31, 2014 On October 10, ... Illinois, the Mesothelioma Applied Research Foundation, in collaboration ... a one-day regional mesothelioma conference geared ... of topics related to mesothelioma and presented by ... covered topics will include imaging, genetics, first-line therapies, ...
    (Date:7/31/2014)... Hoping to attract new customers who are looking for ... is ready to ship out free samples of product. A ... this offer fast and easy: http://www.nutrigold.com/Free-Samples , According ... "We know that every time customers purchase one of our ... their own health or the health of a loved one ...
    (Date:7/31/2014)... NV (PRWEB) July 31, 2014 0-6 Pack ... Tyler Bramlett and physical therapist expert Dr. James Vegher. ... waistlines, fix back pain, relieve digestive issues, tone core muscles, ... a specific sequence of core exercises used to re-train the ... , After a quick 0-6 Pack Abs review, ...
    (Date:7/31/2014)... In today’s world, a good night’s sleep ... and sleep apnea (a medical problem where the airway collapses ... partners of the rest they need to face their daily ... and 20 million people in the United States alone have ... treated; and of those treated, many cannot tolerate their prescribed ...
    (Date:7/31/2014)... Hook Your Ex, a system created by Steve ... emotionally hungry for their partner, to the point of starvation, that ... trick has been taught to hundreds of men and women across ... Your Ex review , Shane Michaels agrees this simple trick is ... breakup a second chance at getting back together with their ex. ...
    Breaking Medicine News(10 mins):Health News:October Events: Regional Conference on Mesothelioma in Chicago 2Health News:October Events: Regional Conference on Mesothelioma in Chicago 3Health News:NutriGold Launches Product Samples Page for its Supplements 2Health News:NutriGold Launches Product Samples Page for its Supplements 3Health News:Zero To Six Pack Abs System Review Exposes Tyler Bramlett And Dr. James Veghers’ New Ab Training Program 2Health News:Zero To Six Pack Abs System Review Exposes Tyler Bramlett And Dr. James Veghers’ New Ab Training Program 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2
    ... ... ... ... ...
    ... ... the leading provider of professional Accounts Receivable based funding and credit management solutions in ... the industries projected to generate the highest number of new jobs over the next ... ...
    ... ... company prepares to launch a range of new products. , ... London, UK (PRWEB) February 19, 2010 -- Freedom Healthnet ( ... launch a range of new products., , ,Freedom Healthnet is already a market leader in ...
    ... ... region’s standing within football’s international arena, it is with great pleasure that international direct ... in support of Asian football. , ... (PRWEB) February 19, 2010 -- As the Official Direct Selling Supporter ...
    ... magnetic resonance imaging (MRI) may help physicians differentiate between ... wrist enabling more targeted therapies unique to each condition, ... the American Journal of Roentgenology . Contrast-enhanced MRI ... bodily structures. Rheumatoid arthritis ...
    ... , ... ... ... ...
    Cached Medicine News:Health News:MDS Announces Substantial Issuer Bid 2Health News:MDS Announces Substantial Issuer Bid 3Health News:MDS Announces Substantial Issuer Bid 4Health News:MDS Announces Substantial Issuer Bid 5Health News:MDS Announces Substantial Issuer Bid 6Health News:United Capital continues to lead in funding 2Health News:Freedom Healthnet Affirms Affordable Private Health Insurance Benefits 2Health News:QuestNet and AFC: Raising the Bar of Asian Football 2Health News:QuestNet and AFC: Raising the Bar of Asian Football 3Health News:Contrast-enhanced MRI could play a key role in differentiating between common types of arthritis 2Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 2Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 3Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 4Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 5Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 6Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 7Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 8Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 9Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 10Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 11Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 12Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 13Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 14Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 15Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 16Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 17Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 18Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 19Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 20Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 21Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 22Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 23Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 24Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 25Health News:Select Medical Holdings Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2009 26
    ... Focus Diagnostics HerpeSelect® 1 ELISA IgG ... or absence of human IgG class antibodies ... the Focus HerpeSelect® 2 ELISA IgG, the ... or expectant mothers for aiding in the ...
    Perfect for loading small volume samples onto agarose and polyacrylamide gels....
    Conducting disposable filter-tips....
    Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
    Medicine Products: